Tanespimycin (17-AAG)

Name: Tanespimycin (17-AAG)
Brand: Selleck Chemicals
SKU: S1141
Rating: 5 (98 reviews)

For research use only.

Catalog No.S1141 Synonyms: CP127374, NSC-330507, KOS 953

98 publications

Tanespimycin (17-AAG) Chemical Structure

CAS No. 75747-14-7

Tanespimycin (17-AAG, CP127374, NSC-330507, KOS 953) is a potent HSP90 inhibitor with IC50 of 5 nM in a cell-free assay, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells. Tanespimycin (17-AAG) induces apoptosis, necrosis, autophagy and mitophagy. Phase 3.

Selleck's Tanespimycin (17-AAG) has been cited by 98 publications

Cell Stem Cell, 2021, S1934-5909(21)00294-0

PubMed: 34388375 ( click the link to review the publication )

Cell, 2019, 36(2):179-193

PubMed: 28162770 ( click the link to review the publication )

Cancer Cell, 2019, 36(2):179-193

PubMed: 31378681 ( click the link to review the publication )

Mol Cell, 2021, 81(6):1170-1186.e10

PubMed: 33571422 ( click the link to review the publication )

EMBO Rep, 2021, e51740

PubMed: 33738926 ( click the link to review the publication )

Elife, 2021, 10e64977

PubMed: 34180400 ( click the link to review the publication )

Cancer Lett, 2021, 512:28-37

PubMed: 33971281 ( click the link to review the publication )

Int J Mol Sci, 2021, 22(5)2538

PubMed: 33802597 ( click the link to review the publication )

Sci Rep, 2021, 11(1):18003

PubMed: 34504167 ( click the link to review the publication )

Sci Rep, 2021, 11(1):11562

PubMed: 34079010 ( click the link to review the publication )

Int J Pharm, 2021, 607:120988

PubMed: 34389420 ( click the link to review the publication )

Sci China Life Sci, 2021, 10.1007/s11427-020-1860-2

PubMed: 33439458 ( click the link to review the publication )

Cell Rep, 2021, 34(6):108726

PubMed: 33567287 ( click the link to review the publication )

Nat Commun, 2020, 29;11(1):2086

PubMed: 32350249 ( click the link to review the publication )

Cell Rep, 2020, 33(7):108397

PubMed: 33207204 ( click the link to review the publication )

Cancers (Basel), 2020, 7;12(4)

PubMed: 32272809 ( click the link to review the publication )

Mol Cell Biol, 2020, MCB.00473-20

PubMed: 33139492 ( click the link to review the publication )

Mol Cell Biol, 2020,

PubMed: 32868290 ( click the link to review the publication )

Phytomedicine, 2020,

PubMed: 32896707 ( click the link to review the publication )

Eur J Cell Biol, 2020, 100(1):151148

PubMed: 33388604 ( click the link to review the publication )

Drug Des Devel Ther, 2020, 14:4605-4612

PubMed: 33149557 ( click the link to review the publication )

G3 (Bethesda), 2020, 4;10(5):1585-1597

PubMed: 32265286 ( click the link to review the publication )

Mol Cell, 2019, 75(4):823-834

PubMed: 31302001 ( click the link to review the publication )

Nat Commun, 2019, 10(1):5043

PubMed: 31695040 ( click the link to review the publication )
Cell Syst, 2019, 8(2):97-108

PubMed: 30797775 ( click the link to review the publication )

Cell Rep, 2019, 27(11):3331-3344

PubMed: 31189115 ( click the link to review the publication )

Cell Death Dis, 2019, 10(10):737

PubMed: 31570706 ( click the link to review the publication )

Cells, 2019, 8(8)

PubMed: 31370342 ( click the link to review the publication )

Front Cell Dev Biol, 2019, 7:204

PubMed: 31608279 ( click the link to review the publication )

Oxid Med Cell Longev, 2019, 2019:2050183

PubMed: 31178953 ( click the link to review the publication )

J Cell Physiol, 2019, 10.1002/jcp.29283

PubMed: 31595984 ( click the link to review the publication )

Cancer Biol Med, 2019, 16(2):220-233

PubMed: 31516744 ( click the link to review the publication )

Sci Rep, 2019, 9(1):5637

PubMed: 30948782 ( click the link to review the publication )

Int J Biol Sci, 2019, 15(2):312-324

PubMed: 30745823 ( click the link to review the publication )

Toxicol Appl Pharmacol, 2019, 371:63-73

PubMed: 30953615 ( click the link to review the publication )

BMC Cancer, 2019, 19(1):102

PubMed: 30678647 ( click the link to review the publication )

Exp Eye Res, 2019, 189:107821

PubMed: 31589841 ( click the link to review the publication )

Mol Cell Biol, 2019, 39(4)e00375-18

PubMed: 30455251 ( click the link to review the publication )

J Natl Cancer Inst, 2018, 110(4):390-399

PubMed: 29202196 ( click the link to review the publication )

Cell Death Dis, 2018, 9(10):944

PubMed: 30237504 ( click the link to review the publication )

Cell Physiol Biochem, 2018, 47(6):2199-2215

PubMed: 29975948 ( click the link to review the publication )

Mol Cancer Ther, 2018, 17(5):1051-1060

PubMed: 29440291 ( click the link to review the publication )

Mol Oncol, 2018,

PubMed: 29797762 ( click the link to review the publication )

J Cell Biochem, 2018, 10.1002/jcb.27397

PubMed: 30378153 ( click the link to review the publication )

Eur J Med Chem, 2018, 158:548-558

PubMed: 30243156 ( click the link to review the publication )

F1000Res, 2018, 7:1906

PubMed: 30881689 ( click the link to review the publication )

Mycoses, 2018, 61(11):853-856

PubMed: 29998564 ( click the link to review the publication )

EMBO J, 2017, 36(5):646-663

PubMed: 28093501 ( click the link to review the publication )
ACS Photonics, 2017, 5(2):487-494

PubMed: 29805987 ( click the link to review the publication )

Br J Pharmacol, 2017, 174(5):409-423

PubMed: 28052321 ( click the link to review the publication )

Cell Mol Life Sci, 2017, 74(3):543-554

PubMed: 27592300 ( click the link to review the publication )

Mol Cancer Ther, 2017,

PubMed: 28619760 ( click the link to review the publication )

Hum Mol Genet, 2017, 26(22):4465-4480

PubMed: 28973376 ( click the link to review the publication )

Sci Rep, 2017, 7(1):4546

PubMed: 28674407 ( click the link to review the publication )

Toxicol Appl Pharmacol, 2017, 329:282-292

PubMed: 28624441 ( click the link to review the publication )

Am J Transl Res, 2017, 9(11):4945-4953

PubMed: 29218092 ( click the link to review the publication )

Onco Targets Ther, 2017, 10:2219-2226

PubMed: 28458565 ( click the link to review the publication )

SLAS Discov, 2017, 22(5):507-515

PubMed: 28324660 ( click the link to review the publication )

Oncotarget, 2017, 8(62):105372-105382

PubMed: 29285257 ( click the link to review the publication )

Medchemcomm, 2017, 8(1):88-95

PubMed: 28670440 ( click the link to review the publication )

Cell, 2017, 170(5):845-859

PubMed: 28823557 ( click the link to review the publication )

Nat Commun, 2016, 7:13122

PubMed: 27959342 ( click the link to review the publication )

Cancer Res, 2016, 76(4):965-73

PubMed: 26676744 ( click the link to review the publication )

Oncogene, 2016, 35(3):333-43

PubMed: 25823022 ( click the link to review the publication )

Oncogene, 2016,

PubMed: 26804171 ( click the link to review the publication )

Oncogene, 2016, 35(29):3854-3865

PubMed: 26657151 ( click the link to review the publication )

Cell Death Dis, 2016, 7:e2089

PubMed: 26866270 ( click the link to review the publication )

Mol Pharm, 2016, 13(11):3724-3735

PubMed: 27653969 ( click the link to review the publication )

Am J Physiol Lung Cell Mol Physiol, 2016, 310(10):L964-74

PubMed: 27036868 ( click the link to review the publication )

Biochem J, 2016, 473(12):1733-44

PubMed: 27059856 ( click the link to review the publication )

Medicinal Chemistry Research, 2016, 10.1007/s00044-016-1553-7

PubMed: ( click the link to review the publication )

Oncotarget, 2016, 7(2):1323-40

PubMed: 26593250 ( click the link to review the publication )
Stem Cells, 2015, 33(9):2738-47

PubMed: 26077647 ( click the link to review the publication )

Mol Cancer Res, 2015, 13(5):923-33

PubMed: 25636967 ( click the link to review the publication )

Cancer Biol Ther, 2015,

PubMed: 25692408 ( click the link to review the publication )

Oncotarget, 2015, 6(22):19228-45

PubMed: 26231043 ( click the link to review the publication )

Oncotarget, 2015, 6(17):14796-813

PubMed: 26142707 ( click the link to review the publication )

Oncotarget, 2015, 51: S659-S660

PubMed: ( click the link to review the publication )

Mol Cancer, 2014, 15:30

PubMed: 24927996 ( click the link to review the publication )

ACS Chem Biol, 2014, 9(10):2237-41

PubMed: 25140805 ( click the link to review the publication )

Exp Gerontol, 2014, 52:55-69

PubMed: 24486130 ( click the link to review the publication )

PLoS One, 2014, 9(10):e111146

PubMed: 25343454 ( click the link to review the publication )

Insect Mol Biol, 2014, 23(6):720-32

PubMed: 25060629 ( click the link to review the publication )

Assay Drug Dev Technol, 2014, 12(9-10):514-26

PubMed: 25506801 ( click the link to review the publication )

Julius Maximilians Universit, 2014, Kumari G

PubMed: ( click the link to review the publication )

Oncotarget, 2014, 5(12):4269-82

PubMed: 24962213 ( click the link to review the publication )

Mol Cell, 2013, 50(3):368-78

PubMed: 23583076 ( click the link to review the publication )

Biochim Biophys Acta, 2013, 1830(11):5184-92

PubMed: 23850472 ( click the link to review the publication )

Mol Cell Biol, 2013, 33(12):2375-87

PubMed: 23572559 ( click the link to review the publication )

Am J Respir Cell Mol Biol, 2013, 10.1165/rcmb.2013-0214OC

PubMed: 24303801 ( click the link to review the publication )

Sci Transl Med, 2012, 4(120):120ra17

PubMed: 22277784 ( click the link to review the publication )

J Exp Med, 2012, 209(2):259-73

PubMed: 22271575 ( click the link to review the publication )

Biochim Biophys Acta, 2012, 1823(4):911-9

PubMed: 22306003 ( click the link to review the publication )

J Biol Chem, 2012, 287(53):44109-20

PubMed: 23144451 ( click the link to review the publication )

Age (Dordr), 2012, 35(3):549-62

PubMed: 22252435 ( click the link to review the publication )

Eukaryot Cell, 2012, 11(11):1324-32

PubMed: 22822234 ( click the link to review the publication )
P Natl Acad Sci USA, 2011, 108(18):7535-40

PubMed: 21502504 ( click the link to review the publication )

J Nat Prod, 2011, 74(6):1491-9

PubMed: 21553813 ( click the link to review the publication )

Purity & Quality Control

Choose Selective HSP (HSP90) Inhibitors

Biological Activity

Description

Features

Displays very low toxicity toward normal cells.

Targets

HSP90 ^[1]
(Cell-free assay)

5 nM

In vitro

17-AAG, an analog of geldanamycin, exhibits greater than 100 times higher binding affinity for Hsp90 derived from HER-2-overexpressing cancer cells (BT474, N87, SKOV3 and SKBR3) or BT474 breast carcinoma cells with IC50 values of 5-6 nM. ^[1] 17-AAG causes the degradation of HER2, HER3, Akt, and both mutant and wild-type androgen receptor (AR), leading to the RB-dependent G1 growth arrest of prostate cancer cells such as LNCaP, LAPC-4, DU-145, and PC-3 with IC50 values of 25-45 nM. ^[2] In addition to inducing apoptosis of Ba/F3 cells transformed with wild-type BCR-ABL with an IC50 of 5.2 μM, 17-AAG has the ability to induce apoptosis of cells transformed with imatinib mesylate-resistant T315I and E255K BCR-ABL mutants with IC50 values of 2.3 μM and 1.0 μM, respectively, by inducing the degradation of both wild-type BCR-ABL protein and mutants. ^[3]

Cell Data

Cell Lines	Assay Type	Activity Description	PMID
A549	MmW5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MoPpTWM2OD1yLkCwNFMxOyEQvF2=	MmTiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
IST-MEL1	M4jxSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MWLJR\|UxRTBwMECwOFA4KM7:TR?=	MlX6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-SNU-1	M33KSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGPmSWxKSzVyPUCuNFAzODdizszN	M3PaPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
FADU	M3v6fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MYTJR\|UxRTBwMECyNFkh\|ryP	NHfUc3U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
C32	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NIfBfZJKSzVyPUCuNFA{ODRizszN	NEXpfXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
D-566MG	Mm[4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NH7jOmNKSzVyPUCuNFA{QSEQvF2=	NWGwXGpXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
LXF-289	Mm\qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NGTBVHhKSzVyPUCuNFA1OTlizszN	NVTke497RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HGC-27	NHT1NoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MWDJR\|UxRTBwMEC1NUDPxE1?	NXzMOW9ZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
RPMI-7951	Mn7ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MoXGTWM2OD1yLkCwO\|E4KM7:TR?=	M1n3SVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HSC-3	M1fme2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NV3DRW8zUUN3ME2wMlAxQTJ7IN88US=>	MnKzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
MIA-PaCa-2	NE\KNW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M1TXcWlEPTB;MD6wNVAxQSEQvF2=	MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
KS-1	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmG1TWM2OD1yLkCxN\|U2KM7:TR?=	NWDiV3RvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
CAL-51	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{LCbmlEPTB;MD6wNVQxPSEQvF2=	NWnWN5hIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
MDA-MB-361	MkGwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NEnROo9KSzVyPUCuNFE1QTVizszN	NUPW[mJKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
TI-73	M1fLPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFLSe5hKSzVyPUCuNFE4QTZizszN	M{TlU\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
AGS	MoHqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NF36OmdKSzVyPUCuNFE6OzhizszN	NUmzdmdURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
NCI-H460	M3;LZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NEfpN5FKSzVyPUCuNFE6PzRizszN	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
A204	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M4HHbGlEPTB;MD6wNlI1QSEQvF2=	M3;zdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
CHL-1	MlLVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NGmxeJNKSzVyPUCuNFIzPTFizszN	NFTNWpM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
DU-4475	MoPMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MUTJR\|UxRTBwMEKyOlEh\|ryP	NV:4bYtIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
CGTH-W-1	NH\ubWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUHyWlJOUUN3ME2wMlAzOzR7IN88US=>	NW\sNnpvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HCC2218	M370Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Mn24TWM2OD1yLkCyOFk1KM7:TR?=	MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
A2780	NX7NPVNGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWjJR\|UxRTBwMEK1N\|Eh\|ryP	MmrGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H720	MmPPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NXO4S3VkUUN3ME2wMlAzPTR4IN88US=>	NF;QWIw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NCI-N87	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2jDdmlEPTB;MD6wNlU6OyEQvF2=	MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
CHP-212	M4H1fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MYnJR\|UxRTBwMEK2Nlgh\|ryP	NHjHOno9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NCI-H23	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2nwNmlEPTB;MD6wNlY3PSEQvF2=	M4HaVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
D-263MG	NH\YbWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M2fYUmlEPTB;MD6wNlc5PiEQvF2=	NFHie4s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
ME-180	NWr0WZFpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MVzJR\|UxRTBwMEK4PVEh\|ryP	MojiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SW982	NFPueFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUXzdY8xUUN3ME2wMlAzQTl7IN88US=>	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
OE19	MlHHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MkDrTWM2OD1yLkCzNFc4KM7:TR?=	M{S3RlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SK-LU-1	M1\x[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXfJR\|UxRTBwMEOwPFIh\|ryP	MmO5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
H4	MmjyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnHzTWM2OD1yLkCzNFkh\|ryP	NWjwenBERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HT-144	MmfUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnPrTWM2OD1yLkCzNFk{KM7:TR?=	MkTPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SK-UT-1	NUPoUXBKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYfJR\|UxRTBwMEOxO\|gh\|ryP	MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
D-336MG	Mn3nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NIfDOWpKSzVyPUCuNFM{ODlizszN	M3zK[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
MDA-MB-175-VII	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NUHy[4pxUUN3ME2wMlA{OzV2IN88US=>	NHfPOIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
GAMG	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MUTJR\|UxRTBwMEO0N\|Uh\|ryP	MkDYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
CP50-MEL-B	NY\1OIp4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NEDmSZNKSzVyPUCuNFM1PSEQvF2=	NIriSHY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
OVCAR-5	Mom4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlTMTWM2OD1yLkCzOFgh\|ryP	NEXtO\|Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
SK-MES-1	MnfCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M4rQXmlEPTB;MD6wN\|YxPiEQvF2=	M3nnSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
VM-CUB-1	NXfjVHI3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NGG3[25KSzVyPUCuNFM3PTdizszN	MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
WM-115	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MnvOTWM2OD1yLkCzO\|YzKM7:TR?=	MkLQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
DSH1	M3XvcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHfXRYRKSzVyPUCuNFM5ODdizszN	NYfnUoFtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
Becker	NH3WT5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXnScZdwUUN3ME2wMlA{QDh3IN88US=>	M4HnPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SW962	MnLCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHr5WYlKSzVyPUCuNFM6PDVizszN	M{[0NVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
TYK-nu	NUnDV\|JbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NILFd4pKSzVyPUCuNFM6QDVizszN	NVT0UY5uRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HO-1-N-1	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHnNTmlKSzVyPUCuNFQxOjFizszN	M3n1N\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
T98G	M4DxTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MWfJR\|UxRTBwMESxNFMh\|ryP	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
ACN	NUHZVXZkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYnJR\|UxRTBwMESxOlIh\|ryP	NVWzboVSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
SW780	Ml23S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NE\TbY1KSzVyPUCuNFQzODNizszN	NUHmdnlMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
Detroit562	M13jWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnPVTWM2OD1yLkC0NlM6KM7:TR?=	NV3KPHd3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
BB49-HNC	NWHGNYlYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIjtT2hKSzVyPUCuNFQzPDNizszN	MonrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
HN	NYrCZpJvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M{Czb2lEPTB;MD6wOFI4OiEQvF2=	NGfZN2o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
H9	M4DNZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVXJR\|UxRTBwMESzO\|Eh\|ryP	MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
VA-ES-BJ	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXXJR\|UxRTBwMES0OFch\|ryP	MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MEL-JUSO	NXvNOYdST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXnZ[YNCUUN3ME2wMlA1PDd3IN88US=>	MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
BT-474	M1HzTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M372V2lEPTB;MD6wOFUh\|ryP	NGDtTlA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
CaR-1	NVHKSXZIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NUezXYl3UUN3ME2wMlA1PTR7IN88US=>	NVvjWJlwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
PSN1	NH25OlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NI\OW2NKSzVyPUCuNFQ3ODNizszN	NUnDWld1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
KYSE-510	NGTifWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHjOVI1KSzVyPUCuNFQ3PDlizszN	NV;4O\|VKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
KP-4	M4rSUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NV:2[ZlVUUN3ME2wMlA1PzV\|IN88US=>	NHS0[lM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
KYSE-410	MlXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{T5PGlEPTB;MD6wOFc4OiEQvF2=	NXOyV3VIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
G-402	NWDiTIFFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MkXaTWM2OD1yLkC0O\|g6KM7:TR?=	M1jmXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
DOK	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MWHJR\|UxRTBwMES5NFIh\|ryP	MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
COR-L88	M33nUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NVn1TpVWUUN3ME2wMlA1QTF{IN88US=>	M1\MNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SKG-IIIa	MoLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M1ThT2lEPTB;MD6wOFk5PiEQvF2=	M3jHWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
AN3-CA	NFrue\|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MmrTTWM2OD1yLkC1JO69VQ>?	NVTDblY{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
SW48	NI[2RnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUHmT\|lEUUN3ME2wMlA2ODN7IN88US=>	NXXGSYoxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
YKG-1	NXrFcppPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVXrV5UyUUN3ME2wMlA2ODdzIN88US=>	M{ThbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
KYSE-150	NUizTWdwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M4\OeWlEPTB;MD6wOVI{PSEQvF2=	NVvEeYgzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HuO-3N1	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MUfJR\|UxRTBwMEWyN\|ch\|ryP	NGnPUmM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
LB1047-RCC	MmD5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MWPJR\|UxRTBwMEWyPVYh\|ryP	MoTqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H2030	M{DhWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MorKTWM2OD1yLkC1OFE1KM7:TR?=	MlH2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
YH-13	MlrFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlPzTWM2OD1yLkC1O\|IzKM7:TR?=	MmrQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
5637	NVHnc4dIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MVLJR\|UxRTBwMEW3OEDPxE1?	NIDhfWc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
LOXIMVI	NV[4VG1XT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MnvoTWM2OD1yLkC1PFczKM7:TR?=	MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
GT3TKB	NXvVWWwyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MmDnTWM2OD1yLkC1PVQzKM7:TR?=	NW\TfG9mRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
TCCSUP	M3zBemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXvJR\|UxRTBwMEW5OlQh\|ryP	M{noNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
EPLC-272H	NHTJPJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVzhNm1UUUN3ME2wMlA3OjB3IN88US=>	MkPtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
LU-99A	NF3Pd\|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVXJR\|UxRTBwME[yN\|ch\|ryP	MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H1755	NVH4dFd7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVuzSZMyUUN3ME2wMlA3OzRzIN88US=>	M1nXWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
KM12	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MYPJR\|UxRTBwME[zOFgh\|ryP	NIrMVWw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
SF295	M{XUVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXfKVXVRUUN3ME2wMlA3PDV{IN88US=>	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MZ2-MEL	NWrvfWlkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MoPmTWM2OD1yLkC2OVU{KM7:TR?=	NH\2WY89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
HEC-1	MnLoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmTQTWM2OD1yLkC2OVg5KM7:TR?=	NV3GUlN3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
SW684	NH;TXHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUHsW2VjUUN3ME2wMlA3PTlzIN88US=>	MmLmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SF539	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{jHO2lEPTB;MD6wOlY5OSEQvF2=	NFzIbYQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
GMS-10	NXjGe4JbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NUO2eWtLUUN3ME2wMlA3Pjl7IN88US=>	NEi1VVc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
MV-4-11	NYXjNJpTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3fZcGlEPTB;MD6wOlgxOyEQvF2=	M2\DSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HT-29	M{PlPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MlW4TWM2OD1yLkC2PVE6KM7:TR?=	MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
23132-87	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NUjJXIQ4UUN3ME2wMlA3QTVizszN	NFPmV2I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
SW620	MlLiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MXLJR\|UxRTBwMEewNlYh\|ryP	NXWzWVVwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HCC1806	NEXN[5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MULJR\|UxRTBwMEexN\|Eh\|ryP	NEPYeIM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
Hs-578-T	NF\2UZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnjQTWM2OD1yLkC3NlA5KM7:TR?=	M4\4Z\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
A2058	MnvhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M1XIT2lEPTB;MD6wO\|IzQCEQvF2=	MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MEL-HO	NHW0cYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M{C3XGlEPTB;MD6wO\|I2PSEQvF2=	MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
HCC2998	MkPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{XBUGlEPTB;MD6wO\|M1PyEQvF2=	M2DRS\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HuO9	NHXtPJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUGyO3ZJUUN3ME2wMlA4PTh7IN88US=>	NH\tcWE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
CAL-39	NYm2cVlvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXjLOIFmUUN3ME2wMlA4PzZ4IN88US=>	M3;oUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
M14	NXfWUVV{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MmHCTWM2OD1yLkC3PVE{KM7:TR?=	MlrEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
BFTC-909	M{jtdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Mn\3TWM2OD1yLkC3PVY6KM7:TR?=	M4n4e\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
TE-11	M3TpU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NH75elVKSzVyPUCuNFc6QTZizszN	NH\QTG49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
TGBC1TKB	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFjKUoNKSzVyPUCuNFgxPDNizszN	NXzGSnYyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
L-363	NHHo[3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXXkNVJxUUN3ME2wMlA5OjB4IN88US=>	MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
A431	M1\DfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXXRT4ZGUUN3ME2wMlA5OjFizszN	MnrOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
MKN45	Mn\3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NITnNJRKSzVyPUCuNFgzOTlizszN	NVXYSHFORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HT-1080	NXvtS5kxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MW\JR\|UxRTBwMEi0N\|kh\|ryP	NUXFZVB{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
OVCAR-8	Mm\4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M4f0[mlEPTB;MD6wPFYzOiEQvF2=	M3PWfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
LCLC-97TM1	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{TNcGlEPTB;MD6wPFczQCEQvF2=	MnHRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
M059J	M4XxdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{[0OGlEPTB;MD6wPVAzPyEQvF2=	NVfYU40yRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
SK-MEL-2	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MUjJR\|UxRTBwMEmwOkDPxE1?	MoDpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
TE-1	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Mlq5TWM2OD1yLkC5NlA1KM7:TR?=	MmP5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
KYSE-180	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2n5WGlEPTB;MD6wPVI3OiEQvF2=	MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
D-247MG	NHvaZ3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NV7uOoN{UUN3ME2wMlA6PDV3IN88US=>	NInPWm89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
8-MG-BA	Mmf2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NWPw[pB1UUN3ME2wMlA6PDd{IN88US=>	M4fvTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NCI-H1792	NEPoVJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M1;BSWlEPTB;MD6wPVYyQCEQvF2=	NWH3WXY5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
MCF7	MlvPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Moq1TWM2OD1yLkC5Olc4KM7:TR?=	M{\qXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NCI-H2122	NHL3eYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M2[4PWlEPTB;MD6wPVc1PSEQvF2=	MlXnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
EFO-27	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MnTSTWM2OD1yLkC5PVk4KM7:TR?=	NYnwd4F3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
LB2241-RCC	NISzfnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Mn7OTWM2OD1yLkGwNFU1KM7:TR?=	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SN12C	NXfFVGxbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWDJR\|UxRTBwMUCxNFch\|ryP	M3LsPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
A498	MmDES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{T5eGlEPTB;MD6xNFE5KM7:TR?=	NHzWWpM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
PANC-03-27	M2LtOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXjJR\|UxRTBwMUCyPFYh\|ryP	MnqxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H1581	NEnjV2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MYPJR\|UxRTBwMUCyPUDPxE1?	NFiyO5I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
U-87-MG	NXPy[IRLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2HU[GlEPTB;MD6xNFMxPyEQvF2=	MkXuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
G-401	M3PDfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1XZe2lEPTB;MD6xNFM2OyEQvF2=	M{PwTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SiHa	NE\jSI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MWfJR\|UxRTBwMUC0PFYh\|ryP	MmLtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
U251	MoOxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHPmeXhKSzVyPUCuNVA2OjVizszN	Mkf3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
MMAC-SF	NWPwS3dRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mn7DTWM2OD1yLkGwOVMyKM7:TR?=	M4HySVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
BB65-RCC	MlvyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M1jzWGlEPTB;MD6xNFU2PCEQvF2=	M4fMOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NKM-1	NVfJSGM4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MkjyTWM2OD1yLkGwOlY3KM7:TR?=	M2H1dlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HD-MY-Z	M2HicWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXuxZm53UUN3ME2wMlExQDd\|IN88US=>	MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
TGBC11TKB	M2[3S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Mo\xTWM2OD1yLkGwPVA{KM7:TR?=	MnSzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
COLO-679	MluyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{PXSWlEPTB;MD6xNVIyOSEQvF2=	MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
TE-8	MlrDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MY\JR\|UxRTBwMUGyOlQh\|ryP	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SK-MEL-28	NF7BOJNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M17sVGlEPTB;MD6xNVMzOSEQvF2=	M4i0[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SH-4	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NY\kXlBCUUN3ME2wMlEyOzV4IN88US=>	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
KALS-1	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1jXbGlEPTB;MD6xNVM6OyEQvF2=	MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
RKO	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVXlNpNLUUN3ME2wMlEyPzZ2IN88US=>	MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
OMC-1	NYrlepFyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXXVPZF4UUN3ME2wMlEyPzl5IN88US=>	NIfvW2Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
BT-549	NX7ZZ\|FFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVmwNFNnUUN3ME2wMlEyPzl7IN88US=>	NV22bpl5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
NCI-H28	NXKx[nV5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NV[5eIk1UUN3ME2wMlEyQDF5IN88US=>	MmDaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
RXF393	M3;1[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MWPJR\|UxRTBwMUG5PFIh\|ryP	M1j5WVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
COLO-829	M3fZfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NV33N\|VCUUN3ME2wMlEzODB3IN88US=>	MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
HMV-II	NX;keopiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYfJR\|UxRTBwMUKwNkDPxE1?	M3W2NVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SW1990	NVqwSVd7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NW[x[3JSUUN3ME2wMlEzOTV5IN88US=>	MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H1437	NXXRTVdtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2jJb2lEPTB;MD6xNlE2PyEQvF2=	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SNB75	NWXrUINyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NYrBWotSUUN3ME2wMlEzOTZ7IN88US=>	NH30VWI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
EW-3	NHTWTYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYDsbHpEUUN3ME2wMlEzPjZzIN88US=>	NEfaVZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
SAS	NX3SOG1QT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M4fRR2lEPTB;MD6xNlY6KM7:TR?=	NIG1ZlQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NCI-H1666	MlK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFrY[5FKSzVyPUCuNVI4PzRizszN	NFjzXpI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
A375	NELnfnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVrJR\|UxRTBwMUK3O\|gh\|ryP	M{PRTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
CAMA-1	NYLjcYs{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYfJR\|UxRTBwMUK5NlQh\|ryP	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
HuP-T4	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NWPUSWVzUUN3ME2wMlEzQTR\|IN88US=>	MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H292	MkjWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NH\6dmFKSzVyPUCuNVMyOSEQvF2=	MnfvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
PC-14	M{T0[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MWLJR\|UxRTBwMUOyNVEh\|ryP	Mlf3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
BPH-1	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2rs[GlEPTB;MD6xN\|QyKM7:TR?=	NXvXSWl[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
GAK	NYPwV5NVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWDJR\|UxRTBwMUO1Olch\|ryP	NIfTSVQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
VMRC-RCZ	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NXrsRY5FUUN3ME2wMlE{PzZ{IN88US=>	NEnKWlU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
SK-MEL-24	NYO0UYdrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MlrzTWM2OD1yLkGzPFch\|ryP	NXfwZW9uRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
LB831-BLC	NFXIeHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NF7NXpRKSzVyPUCuNVM5QDNizszN	MkmxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H2452	M{PKNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MWDJR\|UxRTBwMUO5OVYh\|ryP	NY\Q[VZNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
RT-112	Mk\ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFvhOHZKSzVyPUCuNVQxOzVizszN	NYLnfZpnRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
GP5d	MnrxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFfNPHZKSzVyPUCuNVQyODRizszN	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
LC-2-ad	NWLXUW1lT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NH3qS\|BKSzVyPUCuNVQyOjFizszN	MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MPP-89	NUPDc41WT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NX7UXJJWUUN3ME2wMlE1OTJ3IN88US=>	M1zLN\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NUGC-3	M2\WR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NIrHfppKSzVyPUCuNVQ1PzhizszN	MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
GI-1	NF[3SmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NF\YR45KSzVyPUCuNVQ2PThizszN	NWDOUXp3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HCC1419	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVrJR\|UxRTBwMUS1O\|Yh\|ryP	M{TwOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SW1573	MmLGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M17VRmlEPTB;MD6xOFc2QCEQvF2=	MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H2347	M1TtUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NF7KR3VKSzVyPUCuNVQ5OzlizszN	NFTwVWM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
Mewo	M3rYS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MWHJR\|UxRTBwMUS4PFkh\|ryP	M1vzVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
639-V	NV3Bc3BQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MVzJR\|UxRTBwMUWwNVMh\|ryP	M1v1XFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
AsPC-1	NUHkSnVmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2Ltb2lEPTB;MD6xOVIzPSEQvF2=	MojlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H1648	NHvnS\|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXTVS3NDUUN3ME2wMlE2OjN{IN88US=>	NWKwPYxTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
786-0	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2LhOGlEPTB;MD6xOVM5OSEQvF2=	M3PMTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
ETK-1	MlLqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlG4TWM2OD1yLkG1PUDPxE1?	MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
BxPC-3	M{XldGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M4DZZmlEPTB;MD6xOVk3PiEQvF2=	M1\BPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
CAL-62	NIrUdoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVX5[olPUUN3ME2wMlE3OTZ7IN88US=>	Mn3GQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
HCC1937	M2fkdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M3HkZWlEPTB;MD6xOlI4PSEQvF2=	MlXNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H1299	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MlP2TWM2OD1yLkG2Nlg2KM7:TR?=	M4LNSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SW1088	NFrtUYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NFfBcXBKSzVyPUCuNVY1OTNizszN	NGnzNZY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
FTC-133	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M175bGlEPTB;MD6xOlU1KM7:TR?=	NF3jdVA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
OC-314	M3HuOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MoewTWM2OD1yLkG2Olkh\|ryP	NGXwcWs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
SCC-9	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NGDn[o1KSzVyPUCuNVY4OTZizszN	MnzkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
HT-1376	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M4nLd2lEPTB;MD6xOlk{PiEQvF2=	M1PlbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
U-2-OS	MlLQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NVnzeocyUUN3ME2wMlE4OTd\|IN88US=>	NWWxTmo4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
COLO-824	NYTZOJVRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NFXBbplKSzVyPUCuNVczQTRizszN	NFzGdVk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
BB30-HNC	MkTZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M1jqNWlEPTB;MD6xO\|M{KM7:TR?=	MlrYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H2087	NWPFdGx[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIe5eZRKSzVyPUCuNVc{PjhizszN	M3fhS\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NCI-H2170	NH;CXIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVToXYYyUUN3ME2wMlE4PTN4IN88US=>	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SK-OV-3	M13Y[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MoPwTWM2OD1yLkG3OVcyKM7:TR?=	MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MZ7-mel	NIDkUoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M3Tjb2lEPTB;MD6xO\|Y1QSEQvF2=	NH\lW5E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NCI-H650	M{[4[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVzJR\|UxRTBwMUe2PFIh\|ryP	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
KOSC-2	Mme4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NIPMU\|lKSzVyPUCuNVc4OzRizszN	M2\lW\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SCC-4	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3X3RWlEPTB;MD6xO\|c4PyEQvF2=	NYLTfGQzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
MDA-MB-157	NHW0dXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MoG0TWM2OD1yLkG4NFgzKM7:TR?=	M2q2TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
KYSE-520	NI\RWlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnTuTWM2OD1yLkG4NkDPxE1?	NXTXbHV5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
LK-2	M4W4Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1y2UmlEPTB;MD6xPFMxOyEQvF2=	NV7kc4pyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
KNS-81-FD	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmL3TWM2OD1yLkG4N\|k1KM7:TR?=	M2L3NFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
IGROV-1	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NEjlb4ZKSzVyPUCuNVg1PDNizszN	M{\VbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
DEL	NX3hOIkxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1S2NWlEPTB;MD6xPFQ2KM7:TR?=	MoXNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H1395	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmnGTWM2OD1yLkG4OlgzKM7:TR?=	MoHEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
JEG-3	MonVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmLBTWM2OD1yLkG4O\|A2KM7:TR?=	NHHWXGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
BCPAP	M3fldGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MYLJR\|UxRTBwMUi4O\|Ih\|ryP	M4ThUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
CAL-27	M4XoOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MlzJTWM2OD1yLkG5NFIzKM7:TR?=	M{POcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
RD	MlHjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3joXGlEPTB;MD6xPVEyOyEQvF2=	MoixQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
RVH-421	M2XQWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{GySmlEPTB;MD6xPVEyPiEQvF2=	M4rpcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
Capan-2	NFnPZ5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYPsPVVZUUN3ME2wMlE6OjV4IN88US=>	MlTnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
COLO-680N	NYLPUWJYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3\LTGlEPTB;MD6xPVM3PCEQvF2=	MonrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H1650	NXzFcohlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MlzXTWM2OD1yLkKwNFU4KM7:TR?=	NX7BS2g{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
SBC-5	M4G0W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M3;STmlEPTB;MD6yNFEyQCEQvF2=	MlLHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
U031	NWi1PJpbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVnIdJJZUUN3ME2wMlIxPTR5IN88US=>	M4fIb\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
S-117	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M4TCeGlEPTB;MD6yNFU3PCEQvF2=	NVLveFV2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
DoTc2-4510	NX\jOXNqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVT5XZNYUUN3ME2wMlIxPzZ7IN88US=>	NVjT[ZFIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
AM-38	NX3OWYt3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1z0fmlEPTB;MD6yNFg1QCEQvF2=	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
A172	M4rNTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M4ft[2lEPTB;MD6yNVAzOiEQvF2=	M2XzWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HPAF-II	NYHyZYdPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MVfJR\|UxRTBwMkGyOlQh\|ryP	M2\ldVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
769-P	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFvudVBKSzVyPUCuNlEzQCEQvF2=	M{XBUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
MFE-280	M4DvRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXzJR\|UxRTBwMkGyPVgh\|ryP	M3TLflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
TE-9	NUDiTGZxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M{nwdWlEPTB;MD6yNVc5PiEQvF2=	MkfXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
C2BBe1	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M4LxXGlEPTB;MD6yNlE6KM7:TR?=	MkC2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
EoL-1-cell	M2jpOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHPEUm5KSzVyPUCuNlIzODNizszN	M{XLXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
G-361	MlH4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NGnLXJlKSzVyPUCuNlI3QDJizszN	MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
KYSE-270	M3nXcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVHJR\|UxRTBwMkOwPFQh\|ryP	MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
TK10	NHzNSYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MX;JR\|UxRTBwMkOxNVch\|ryP	NXfPOJFZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
ML-2	M3jtOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHHLcZlKSzVyPUCuNlMyOTlizszN	NUHNZlRURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
MHH-ES-1	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1L4d2lEPTB;MD6yN\|Y5OSEQvF2=	NEPsb3I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
BHY	NXr4[FI3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MY\JR\|UxRTBwMkO2PVEh\|ryP	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
LS-513	M360Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NH[2dodKSzVyPUCuNlM6PjFizszN	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
COLO-678	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NF;OcZVKSzVyPUCuNlQxPDRizszN	NHjyWHE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NCI-H747	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmTCTWM2OD1yLkK0NVY6KM7:TR?=	MoHlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
K5	Ml3hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NXfENZdiUUN3ME2wMlI1OzhizszN	M12wNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
OS-RC-2	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2nDV2lEPTB;MD6yOFUxQSEQvF2=	MmraQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
KINGS-1	NUjQRoxET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXfWc5cyUUN3ME2wMlI1PTJ7IN88US=>	M{XyV\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SCC-25	M2m0TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXnIVFVRUUN3ME2wMlI1PTZ\|IN88US=>	M3WwZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
CAPAN-1	NYfpO2hUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MkG4TWM2OD1yLkK0O\|g{KM7:TR?=	MkS2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
ESS-1	M3PiVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NYrLVYRMUUN3ME2wMlI1QDB3IN88US=>	MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
TE-6	NYfyO3RkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NYDhSVF6UUN3ME2wMlI2PzVizszN	M1m1UlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
LB2518-MEL	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFq4dZpKSzVyPUCuNlU4PzdizszN	NYTBOFkzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
COLO-800	NXPyRlFzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NYTQbWlxUUN3ME2wMlI2QDF{IN88US=>	MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
LU-134-A	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXfJR\|UxRTBwMk[xN\|Yh\|ryP	MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H1155	NFWzWGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYHBcHVFUUN3ME2wMlI3OTZ{IN88US=>	MnSwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
MFM-223	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Mon3TWM2OD1yLkK2N\|Y{KM7:TR?=	MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
HTC-C3	MmfXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlHKTWM2OD1yLkK2OVA3KM7:TR?=	NEG0bnc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
HCT-116	NVPaSnVHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MlXOTWM2OD1yLkK2OVk6KM7:TR?=	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
Ca-Ski	NFzBV25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NG\EOIJKSzVyPUCuNlY3PzhizszN	Mkf3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SBC-1	M2Tnd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGPxTWNKSzVyPUCuNlY4PDJizszN	NFjWUHQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NB69	MlTYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MkLDTWM2OD1yLkK3NFg4KM7:TR?=	M3W3WlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
J82	NFHsbVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYrHc2Q1UUN3ME2wMlI4OjZ3IN88US=>	NGfUN5g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
U-118-MG	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MkLuTWM2OD1yLkK3OVc6KM7:TR?=	M1W4NlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NCI-H1355	MlP5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NWDm[pRUUUN3ME2wMlI5ODd2IN88US=>	Mn7EQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H1048	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXrJR\|UxRTBwMki5OVYh\|ryP	MnP5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SW954	MlXYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmTkTWM2OD1yLkK5NlI4KM7:TR?=	NIjPc2w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NMC-G1	M1;tfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFLrZYdKSzVyPUCuNlkzPzdizszN	NVrWe2xSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
SW1710	NIjVOGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVTJR\|UxRTBwMkm0PVQh\|ryP	MnzmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
KY821	M3;3fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MmS3TWM2OD1yLkK5PFczKM7:TR?=	M1fLN\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HCC38	NVnxSYRFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NU\JUYprUUN3ME2wMlMxODd6IN88US=>	MmXnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-SNU-5	NUj5V2FHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWXJR\|UxRTBwM{C1OEDPxE1?	NVXtRnN[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
ES8	M37PdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFu2R25KSzVyPUCuN\|A4QDRizszN	MmHQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
COLO-792	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{jxSGlEPTB;MD6zNVI2OSEQvF2=	Mlq2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
BFTC-905	M{e2WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGjV[JlKSzVyPUCuN\|E2OjFizszN	M{Hk[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
ChaGo-K-1	NVf1WYR5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1fnXWlEPTB;MD6zNVcyPSEQvF2=	M2C5Z\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
Daoy	Mk\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NGH0bZFKSzVyPUCuN\|E4OjNizszN	M{j6XVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SJSA-1	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFjYdlNKSzVyPUCuN\|E5PDdizszN	NF;pTGE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
KNS-62	NIPOTYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Ml;xTWM2OD1yLkOyNFg5KM7:TR?=	MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
CAKI-1	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NV3iW415UUN3ME2wMlMzOTFzIN88US=>	MnfzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
UACC-62	NF7J[HVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MmfZTWM2OD1yLkOyNlI4KM7:TR?=	M3n6TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HuCCT1	Ml7VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M4K5RmlEPTB;MD6zNlI5OyEQvF2=	MoLqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
CTB-1	MnHRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MoXITWM2OD1yLkOyO\|U{KM7:TR?=	MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NTERA-S-cl-D1	NF7TUWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYS4XFJ[UUN3ME2wMlMzQDN4IN88US=>	Ml;VQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
T-24	Mor6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{\NNmlEPTB;MD6zN\|E2QSEQvF2=	Mo\iQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
KYSE-70	NH\XVHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Mnr4TWM2OD1yLkOzNlg{KM7:TR?=	M3fNOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SW626	MmfiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmrUTWM2OD1yLkOzOVMzKM7:TR?=	NFzZUW49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
LB996-RCC	NVfWZ2ZtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NV\vdmxCUUN3ME2wMlM{PjF7IN88US=>	MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
DMS-273	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{XVR2lEPTB;MD6zN\|kyPiEQvF2=	NVuxW2lSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
SW1783	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NIi3bYlKSzVyPUCuN\|M6QTdizszN	MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
KU812	MnrWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlnrTWM2OD1yLkO0NFM5KM7:TR?=	NGG5PGU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
HSC-2	NWjYTlI1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1TNUmlEPTB;MD6zOFA2OyEQvF2=	NXHnV4V2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
A3-KAW	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NXvIXYx[UUN3ME2wMlM1OTZ{IN88US=>	NFHSdWw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
COLO-684	NVLpbJI3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NUnXPFROUUN3ME2wMlM1PTBzIN88US=>	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H2405	MmrwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2HRZWlEPTB;MD6zOFY{OSEQvF2=	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H2228	M1zJbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NF\rc41KSzVyPUCuN\|U{PTdizszN	NH7tSZA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NB13	M3PRSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MmfDTWM2OD1yLkO2PFI6KM7:TR?=	NEjne2s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
no-11	M1;YOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MUDJR\|UxRTBwM{[5OUDPxE1?	NFq4So09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
DK-MG	MnWyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NXzBUIRxUUN3ME2wMlM4OTh6IN88US=>	M4[5NFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NBsusSR	M2L1d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MkD1TWM2OD1yLkO3Nlg2KM7:TR?=	MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
KP-N-YS	MoD4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Moj3TWM2OD1yLkO3OFY{KM7:TR?=	NGH4SYY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
CFPAC-1	NITHcHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M3WwWmlEPTB;MD6zO\|UyQCEQvF2=	M3TEW\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
KARPAS-45	MmTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmfwTWM2OD1yLkO3PFYzKM7:TR?=	NGPBV4U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NCI-H1793	MkDJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnXhTWM2OD1yLkO4OVEh\|ryP	Mlv2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
HCE-T	M3zI[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NEX6OZdKSzVyPUCuN\|g3ODNizszN	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H520	NHnoVHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnG0TWM2OD1yLkO4O\|A{KM7:TR?=	M4HWZ\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HCC2157	MmPCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NI\pbopKSzVyPUCuN\|g4QDFizszN	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
EW-18	MnzSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3LkXGlEPTB;MD6zPFk1OSEQvF2=	Mnu4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
RO82-W-1	M3[2OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MlixTWM2OD1yLkO5Olk6KM7:TR?=	M3TYXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HuP-T3	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MX3JR\|UxRTBwNECxOFMh\|ryP	NXfKNZpJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
PANC-10-05	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{TrU2lEPTB;MD60NVE4KM7:TR?=	NGX3VIg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NCI-H1703	M371Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NUf3VJVMUUN3ME2wMlQyPDR4IN88US=>	M4PvNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
TE-10	M2TvcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXfJR\|UxRTBwNEG0OFch\|ryP	MlHSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
HOS	NInNc5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NFnBeW9KSzVyPUCuOFE3QDJizszN	NY\0[3lVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
LN-405	NIqzNoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MlmyTWM2OD1yLkSxOlg4KM7:TR?=	MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
A427	MmrwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3zqN2lEPTB;MD60NVk5OSEQvF2=	M4roc\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
CAL-12T	MkD3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHfXcmZKSzVyPUCuOFI4QCEQvF2=	NGPGcoo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
SW756	NX\WSGlnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MXLJR\|UxRTBwNESxPFMh\|ryP	MkPMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
YAPC	MmjkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M334SWlEPTB;MD60OVA5KM7:TR?=	MmLMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
GOTO	MoO5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M33ReGlEPTB;MD60OVE3KM7:TR?=	MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
C3A	NGXTfXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Ml3qTWM2OD1yLkS1OFM4KM7:TR?=	MnT4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
UM-UC-3	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NYf6b5B6UUN3ME2wMlQ2PDdizszN	Mo\PQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H1573	NIm2[pdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NWD6bmdKUUN3ME2wMlQ2PTZ7IN88US=>	MmTsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
LS-411N	NXiyRnZiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MnW1TWM2OD1yLkS2OVI4KM7:TR?=	MoCyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
COR-L23	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3;VZmlEPTB;MD60Olc3PCEQvF2=	MmC5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
HCE-4	M4m0PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MYXJR\|UxRTBwNEe0OFYh\|ryP	NUnQWW9yRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
NCI-H2291	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHfrfWlKSzVyPUCuOFc5QTZizszN	M{DVO\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
A101D	NYTqb\|BQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MmqzTWM2OD1yLkS4NFU{KM7:TR?=	NYm0d\|FLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HT-3	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NF\rd5dKSzVyPUCuOFgzOTdizszN	MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
HOP-62	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NYrKUIlUUUN3ME2wMlQ6QDZ3IN88US=>	NV;PfmRRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
PC-3	M{i4Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGG4b5JKSzVyPUCuOVE2ODdizszN	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
CTV-1	MojTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2HzVGlEPTB;MD61NlY3QSEQvF2=	NV64dpk1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
PANC-08-13	M3;LVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MmnoTWM2OD1yLkWzNVc4KM7:TR?=	MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
CAL-120	NHvHSmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVjJR\|UxRTBwNUOzPVkh\|ryP	MkPNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
UMC-11	NWHLeHpUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1LiSWlEPTB;MD61OVI{PCEQvF2=	NXf5TnA1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
MSTO-211H	NUW2Z4RwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NWTtVHNDUUN3ME2wMlU2PzZ{IN88US=>	NU\qWHJXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
NCI-H2126	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1y0WGlEPTB;MD61OlgyPSEQvF2=	NXLpeIxqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
SNU-C2B	NGfHXJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M4L3ZmlEPTB;MD61O\|k4PyEQvF2=	MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
DBTRG-05MG	M{\EXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MY\JR\|UxRTBwNUiwOVMh\|ryP	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MKN1	M3PXSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFm5eGdKSzVyPUCuOVg4QDNizszN	NYXHPFdORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
ES3	NE\6NHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVjCOnY{UUN3ME2wMlU6OTJ2IN88US=>	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
OVCAR-3	NFzLZmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M1\1[GlEPTB;MD61PVM1OSEQvF2=	NUfD[lVMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
ACHN	M{W4UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NWDOOI5ZUUN3ME2wMlYxPTZ7IN88US=>	NFL0bIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
SW872	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmrXTWM2OD1yLk[wO\|Y{KM7:TR?=	NE\4OoY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
CP66-MEL	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MlfOTWM2OD1yLk[wPVY6KM7:TR?=	M4LBclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NCI-H661	MlLKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MYTJR\|UxRTBwNkGxNFQh\|ryP	M17wb\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
UACC-893	NV;qSXAxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NGW4fnBKSzVyPUCuOlM3QDFizszN	NFPDPJU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
JVM-3	NH60OHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M1[0c2lEPTB;MD62N\|gxPCEQvF2=	MlTLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SF268	NV3ScG1lT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1yzeWlEPTB;MD62OFM1QSEQvF2=	MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
OCI-AML2	M2rENWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVPJR\|UxRTBwNkWzPVch\|ryP	M3jLUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
RPMI-8226	MkPDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NV7ZOnhRUUN3ME2wMlY3OzJ\|IN88US=>	M37IeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
MKN28	MnPnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlnnTWM2OD1yLk[2OlI1KM7:TR?=	NVjWSIlyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
MDA-MB-453	NVjRNI5nT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1LjN2lEPTB;MD62O\|E5KM7:TR?=	M3vJelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
BV-173	NV:4b3lbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MlW2TWM2OD1yLk[4Olc6KM7:TR?=	M4O5c\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NCI-H358	NInabHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Mo\RTWM2OD1yLk[4O\|I3KM7:TR?=	Mo\zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H1651	M{XGfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MlfzTWM2OD1yLkeg{txO	NWrDUXlVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
MDA-MB-415	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MYnJR\|UxRTBwN{C4Nlkh\|ryP	NUTCRmV6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
8305C	NGPMWnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MYjJR\|UxRTBwN{K0PVgh\|ryP	NYTkUIlvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
EFM-19	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXnJR\|UxRTBwN{O2O\|Eh\|ryP	MnO1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
RERF-LC-MS	NF\EWJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXj5XooxUUN3ME2wMlc1PjF\|IN88US=>	MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
A388	M{D5[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M3HB[mlEPTB;MD63OlQ3PyEQvF2=	M3m2UFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
GI-ME-N	Ml36S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2\2NWlEPTB;MD63O\|I{PSEQvF2=	MnLBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
IGR-1	NYrvZodrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVPqRY5VUUN3ME2wMlc6ODR\|IN88US=>	Ml3EQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
LNCaP-Clone-FGC	NXLzR29XT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2\aO2lEPTB;MD64NFAxPCEQvF2=	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SK-MEL-3	Mn;sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M4rHZ2lEPTB;MD64NVUxQCEQvF2=	NGLXNZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
UACC-257	NXHYbZhvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mn;6TWM2OD1yLkiyNlMyKM7:TR?=	NX;PU4FrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
OE33	NFOyNoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M3rQbWlEPTB;MD64OVExOSEQvF2=	M2nPXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
QIMR-WIL	M4rwRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHT6NYpKSzVyPUCuPFUyPDFizszN	MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H2009	MlzzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3HhWGlEPTB;MD64OVMyOSEQvF2=	NYLxTnRYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
NCI-H522	NGPnXFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MXPJR\|UxRTBwOEe3PFMh\|ryP	MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
Saos-2	NGPZfnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYW0c\|h6UUN3ME2wMlg4QDdzIN88US=>	NYfuflczRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
NB17	M2DwZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NX3rT5ZzUUN3ME2wMlg5ODJ3IN88US=>	MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
D-392MG	M3z4[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NF;mb2JKSzVyPUCuPFk{PTZizszN	MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SHP-77	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVvJR\|UxRTBwOUC0PFUh\|ryP	MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SK-MEL-30	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{WzXWlEPTB;MD65NVE5PSEQvF2=	MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
GCIY	MmnIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NXL0ZpVFUUN3ME2wMlkyQDR\|IN88US=>	NHO4foQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
HCC70	NHmwc41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NIPyT29KSzVyPUCuPVIxPTlizszN	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
LU-65	NU\X[HFNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M4fzbGlEPTB;MD65NlU6OSEQvF2=	NWn5bop6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
NCI-H1563	NH\XTWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NIj3TFBKSzVyPUCuPVQ5PjVizszN	NUX4XVNHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
KURAMOCHI	NIHjdndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NGf6eZBKSzVyPUCuPVUyQTJizszN	NX7nPYxnRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
PA-1	NEPnTJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnT0TWM2OD1yLkm1OFI1KM7:TR?=	MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NOS-1	MkThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MkPiTWM2OD1yLkm3OFg6KM7:TR?=	MmjuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H69	M3:zdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NYTNdZhxUUN3ME2wMlk4PjN2IN88US=>	M4jYW\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
KYSE-450	NUjnUIVoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVHlbXdUUUN3ME2wMlk5PjJ4IN88US=>	MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
8505C	MoTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Mn7ETWM2OD1yLkm5PVgzKM7:TR?=	NHnxSpQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
TGBC24TKB	MmqyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnW2TWM2OD1zLkCwNFg1KM7:TR?=	MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
PFSK-1	NVrhbpV4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NEHwSlNKSzVyPUGuNFE1OjhizszN	NVXmOFVPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
EKVX	NVPMTFFbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NWq0d\|VGUUN3ME2xMlA{OTJzIN88US=>	M2m5T\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
RCM-1	NEXlU2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NGDEU5JKSzVyPUGuNFU2ODdizszN	MknJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SW900	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NV3Md3VkUUN3ME2xMlA4QDNizszN	M3nxeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
D-542MG	M4fZXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1OzWWlEPTB;MT6wO\|g2PSEQvF2=	MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SK-PN-DW	NH[wbpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NX76Ro1OUUN3ME2xMlExODV4IN88US=>	NX;SVZFHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
NCI-H727	NGXXdmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXnDNW9jUUN3ME2xMlExOTV2IN88US=>	M2fXfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SW837	MlTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NUDDRWlHUUN3ME2xMlExQTV2IN88US=>	Ml;0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
BT-20	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1zwdGlEPTB;MT6xNVIxPCEQvF2=	MmfLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
RH-18	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1vXdWlEPTB;MT6xN\|ExOyEQvF2=	NX7lXHdMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
TE-12	Ml\uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NYHJdHR2UUN3ME2xMlE{OzN\|IN88US=>	MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NB10	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVP5OIJCUUN3ME2xMlE{OzR2IN88US=>	MnnOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
AU565	M3fhN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MU\JR\|UxRTFwMUW5O\|Mh\|ryP	NYHkSVdZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
OAW-42	M2X4PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{XufWlEPTB;MT6xPFMxPiEQvF2=	M{nwbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
DJM-1	NGjP[YhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M1j3[GlEPTB;MT6xPVg5OSEQvF2=	MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
HH	NGWwU2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M{TnSGlEPTB;MT6yN\|g{OSEQvF2=	MlvCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
LAMA-84	MnfwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NX3aOZkyUUN3ME2xMlI4Ozl2IN88US=>	NHzIUIc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
KNS-42	NX7YRYo5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MlLhTWM2OD1zLkOwNlk3KM7:TR?=	MmnLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H2052	M3H6Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MkXvTWM2OD1zLkOwOVA4KM7:TR?=	MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MLMA	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Mk\STWM2OD1zLkOyOFA4KM7:TR?=	MkLXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NB12	M1:0TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MWrJR\|UxRTFwM{W2N\|Yh\|ryP	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H1838	MlzuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NYDjT3BCUUN3ME2xMlM3OzB4IN88US=>	MnXDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H526	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MnPoTWM2OD1zLkO3PFU{KM7:TR?=	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
LS-123	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Ml65TWM2OD1zLkO5NFk1KM7:TR?=	NEfPOnY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
HDLM-2	NH7V[FZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYj1WFBjUUN3ME2xMlM6OjdzIN88US=>	NELSU3M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
MC-IXC	NYL5c4w4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MlPSTWM2OD1zLkSyN\|cyKM7:TR?=	MmmwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
HCT-15	MkSzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MXjJR\|UxRTFwNEOwOlgh\|ryP	MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H596	NYnVXHRrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MnPiTWM2OD1zLkS1NFYyKM7:TR?=	NIrEVpE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
ZR-75-30	Mof5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmG1TWM2OD1zLkS3NFgzKM7:TR?=	MlSxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
A704	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MWLJR\|UxRTFwNk[1OlMh\|ryP	MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
OVCAR-4	M1HhTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXrJR\|UxRTFwNkm2NFch\|ryP	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SW1417	MljkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MV\JR\|UxRTFwN{K4OFkh\|ryP	NWnVdZpQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
CAS-1	M4fCe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXXYd41XUUN3ME2xMlc{QTN4IN88US=>	NHW2SYc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
IST-SL1	NX3Xb3F[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1LnT2lEPTB;MT63PVc2QSEQvF2=	MkXmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
A253	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFW5c49KSzVyPUGuPFIzOzlizszN	MkXOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
EW-16	NITIfZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MXvJR\|UxRTFwOEK4O\|Uh\|ryP	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SK-NEP-1	M3H5Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MV3JR\|UxRTFwOE[5PFgh\|ryP	NITDflc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NCI-H226	Mn7PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NIDRdYxKSzVyPUGuPFk{PTlizszN	NH7G[GQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
HOP-92	M{j2T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXvJR\|UxRTFwOU[wPVkh\|ryP	M1rKWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NCI-H441	MnPjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlG4TWM2OD1{LkCyN\|M4KM7:TR?=	NHnJXm49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
LU-139	Mn6zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NI[0U5RKSzVyPUKuNFMyOTRizszN	MlHXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SJRH30	NELENFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYDObGh3UUN3ME2yMlA1OjV\|IN88US=>	MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MG-63	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NE\STJlKSzVyPUKuNVQyOTFizszN	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NH-12	NVe1TpVPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWfJR\|UxRTJwMUWwNFYh\|ryP	M{nXcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NB7	NETIXndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M2HFU2lEPTB;Mj6xPVY4OyEQvF2=	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
LB771-HNC	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2nDWGlEPTB;Mj6yNFU6PSEQvF2=	NYXTd3JxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HCC1569	NGLCPGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M1;ENmlEPTB;Mj6yOFU5OyEQvF2=	MlLxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
D-283MED	M{KxTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M2nz[WlEPTB;Mj6yOFc5OiEQvF2=	M1jsUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
J-RT3-T3-5	M4i3UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M2PwPGlEPTB;Mj6yOVM2OSEQvF2=	NELLWmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
ATN-1	M1yxOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MmXkTWM2OD1{LkOzNFgzKM7:TR?=	NXLj[VV6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HCC1954	NH\HeXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Mm\hTWM2OD1{LkO0OFA5KM7:TR?=	MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SCC-15	NGrNdJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHrtdJFKSzVyPUKuN\|k{OTJizszN	MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
COLO-668	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MkXlTWM2OD1{LkSzNkDPxE1?	NFXxZ249[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
LB373-MEL-D	M{LzU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Moi4TWM2OD1{LkW0Olc4KM7:TR?=	NEn3Ooc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
no-10	NYPxS\|NsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2rPXmlEPTB;Mj61OFk1PyEQvF2=	NUfkVHBvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HT-1197	NVPXZWpvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NEHaT\|NKSzVyPUKuOlMyQDhizszN	MkXBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
DU-145	NEOzS3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MkLxTWM2OD1{Lke5NVYzKM7:TR?=	MkLqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SK-N-AS	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NEf3[HhKSzVyPUKuPFQ3QTJizszN	MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MOLT-4	NIDMdZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NEnJNo1KSzVyPUKuPFU{OjJizszN	MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
EW-22	M{TVOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Mom5TWM2OD1{LkmyPFQyKM7:TR?=	MmXEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
DB	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NESxNmpKSzVyPUKuPVc4PTlizszN	NVPCZ3MxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HL-60	MorhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MkPETWM2OD1\|LkC0N\|c3KM7:TR?=	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SK-N-DZ	MoP1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MWTJR\|UxRTNwMEWwO\|Uh\|ryP	M4G3NVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NY	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVfT[mdTUUN3ME2zMlA5PTR{IN88US=>	M2P0[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
T47D	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M37tRWlEPTB;Mz6xNFU2QCEQvF2=	MlHjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H2029	NIOxRotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M13QPWlEPTB;Mz6yNlQ4PyEQvF2=	NXrOSm42RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
KARPAS-299	MmfSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M1;qRmlEPTB;Mz6yOlAzPyEQvF2=	NF\3fm89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
KM-H2	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NEK5dItKSzVyPUOuN\|A3QCEQvF2=	M2T2cVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
CHP-134	NXnTWVNqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVzlflRsUUN3ME2zMlQ4OzlizszN	M3\s[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
22RV1	NH\BeJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NF3ONXFKSzVyPUOuOFkyPjhizszN	NES4c\|k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
NB5	M3q2emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NVLp[3JMUUN3ME2zMlUxPjh7IN88US=>	NH\hdXQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
CW-2	M4PhPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NH3BN3pKSzVyPUOuOVU{OTRizszN	MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
EFO-21	MkSwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NVzTXphoUUN3ME2zMlU3QTRizszN	NWTJR4diRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HuH-7	NVrYPIs5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NEPtVFdKSzVyPUOuOVg1OTRizszN	M3:yXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
ALL-PO	NWf3[FU6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MmiyTWM2OD1\|Lk[yN\|M2KM7:TR?=	NXrYRo1iRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
EM-2	NVTSNnVuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVLiZlk2UUN3ME2zMlY6ODFzIN88US=>	M4Px[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
KLE	M{SwOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NITIfVFKSzVyPUOuO\|MxOjlizszN	MnXNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NEC8	NYfvbWtGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NWHRfXRRUUN3ME2zMlkyQDB6IN88US=>	NH3VOVA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
KP-N-YN	Mn7hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3m0WGlEPTB;Mz65N\|Q4PiEQvF2=	NX3qWGk5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
SK-MEL-1	M2\KeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{HNb2lEPTB;ND6wN\|UyQCEQvF2=	MkPEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
CAL-54	M1q1dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVHJR\|UxRTRwMEW5NUDPxE1?	NWLHPYRVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
MS-1	NWm3[2JJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1qyfWlEPTB;ND6xOlE2PSEQvF2=	M{LpcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NCI-H209	NYrQe3NuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NWfXV404UUN3ME20MlI6QTl7IN88US=>	Mo\LQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NOMO-1	NXy3PGpHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NWSycJZ4UUN3ME20MlMzOTNzIN88US=>	NGH4U2I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
RPMI-2650	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MnzZTWM2OD12LkO2N\|I4KM7:TR?=	MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H810	M{LQNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MYjJR\|UxRTRwM{m3N\|Yh\|ryP	NFq2fHM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
Ca9-22	MomyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MVfJR\|UxRTRwNEW2PVEh\|ryP	NWX1PWpFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
ES4	NHfYXJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NWrVS49NUUN3ME20MlQ4ODl3IN88US=>	M1X2VlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
ES6	M4DnTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnXDTWM2OD12LkS5OlU4KM7:TR?=	MlGxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
DMS-114	NGS1[XpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NEDS[GlKSzVyPUSuOVQ3QTFizszN	MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
ONS-76	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MX;JR\|UxRTRwNUe5OUDPxE1?	NYiyNGJKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
K-562	NX3hXWl7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MUPJR\|UxRTRwN{O4NVQh\|ryP	M1T6XFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
MHH-NB-11	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MX;JR\|UxRTRwN{W0OlEh\|ryP	M{\YNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
Calu-3	NH3tSHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NGr0W5dKSzVyPUSuO\|g2PDhizszN	M12wb\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HT55	M3uxZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MmfsTWM2OD12Lki0OVQ2KM7:TR?=	NFzkZmk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
SK-N-FI	NFjCOG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NW\Qb3VZUUN3ME20Mlg2ODB7IN88US=>	MkDsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
ES1	NVGwWlBMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NWHnSY14UUN3ME20Mlg3ODV5IN88US=>	M4fxWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SF126	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MYPJR\|UxRTRwOUOxPFQh\|ryP	NFT2fnk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
ES5	NWHTcFNwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIDlWG9KSzVyPUWuNVI1OjdizszN	MkLoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
LoVo	MkPpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MXnJR\|UxRTVwMUW4O\|Eh\|ryP	M2L0SlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SNU-387	NU\XZ\|B{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NYTLXYNFUUN3ME21MlMzOzN7IN88US=>	MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
C8166	NYjkfVNyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MY\JR\|UxRTVwM{[zN\|kh\|ryP	NYG5Z\|c5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
LS-1034	MoX4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NGDHNZpKSzVyPUWuOFI{ODdizszN	M1vGNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
GR-ST	NVzSTpI2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NHjUWWdKSzVyPUWuOVIzODFizszN	M3e2ZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NCI-H1092	MmThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NVzP[YU4UUN3ME21MlczQDR\|IN88US=>	M3HzW\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
647-V	NUDCXGtjT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NEC5TWFKSzVyPUWuO\|Q4ODZizszN	Mn7MQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
EW-13	NVWweIRvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIn1VWdKSzVyPUWuO\|Y3OjdizszN	MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
KGN	M1fyWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MUPJR\|UxRTZwMEm5NlEh\|ryP	MnfPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
D-423MG	MnzKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NVTQfJhrUUN3ME22MlQxOjh2IN88US=>	M{XYbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
ECC10	NUXQeY4{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1fEPGlEPTB;Nz6xNFExOSEQvF2=	M2Tsb\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
TE-5	NEXxPINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M4rrSmlEPTB;Nz60NVI6QCEQvF2=	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
P12-ICHIKAWA	NYDNNmtVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MXHJR\|UxRTdwNEW1NlMh\|ryP	MkPsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H82	NXPmNIRVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NEOwSHhKSzVyPUeuOFU4ODFizszN	M4rPR\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
NCI-H1993	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M4jGfmlEPTB;Nz64N\|A3OyEQvF2=	NXraTnhERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
RH-1	NUW3OHR5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NHnKdo9KSzVyPUeuPFUzPDRizszN	MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
SW948	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVjJR\|UxRTdwOU[wOFkh\|ryP	MoPZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
CAL-33	M33yemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NIHCWodKSzVyPUeuPVk6OzhizszN	MmT2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
U-266	M1;K[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1rkdWlEPTB;OD6xOVc4PyEQvF2=	M13Ge\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
CAL-72	NFLPW2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M3PDW2lEPTB;OD6yNFMzKM7:TR?=	Mne5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SNU-423	MkfIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MXXJR\|UxRTlwM{[2OlYh\|ryP	MnPQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
KG-1	M4D2Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1W5TmlEPTB;OT61PFQ2PiEQvF2=	NYPuOXFZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HCC1395	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NULtblFRUUN3ME25MlkzOzV{IN88US=>	NHjj[lA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
BE-13	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NXvZWYtnUUN3ME2xNE45QDl{IN88US=>	M2T0cVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
MKN7	Mn3MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnLsTWM2OD1zMD65O\|Y2KM7:TR?=	Mo\RQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
697	NFThdIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Ml\yTWM2OD1zMT6xOFczKM7:TR?=	NYK0T2d6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
LU-135	M3fwR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFnxcWVKSzVyPUGxMlI{ODdizszN	M3nk[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
ES7	M1jXO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NV\HdZExUUN3ME2xNU4{OzF\|IN88US=>	M4TteVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SK-HEP-1	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MkXFTWM2OD1zMT63OlQ3KM7:TR?=	NHjw[oY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
BEN	NVW4ZXQ2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Ml3oTWM2OD1zMT64OVEh\|ryP	NWjwSllFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
NCI-H1770	MmjKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MULJR\|UxRTF{LkGyOkDPxE1?	Mnz5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SW13	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Mn7kTWM2OD1zMj6xOVQyKM7:TR?=	MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MZ1-PC	NFjMO5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M2nkOWlEPTB;MUKuOVQ2OiEQvF2=	NHjLWIg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
Mo-T	Mk\JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MV;JR\|UxRTF{Lke0NlEh\|ryP	MkLFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
HLE	NXXNSVZiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Ml7sTWM2OD1zMj64NlE2KM7:TR?=	MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
RCC10RGB	M3:4d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXnJR\|UxRTF\|Lk[3NUDPxE1?	NUnrUnNORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
COLO-320-HSR	M3\sSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXXJR\|UxRTF\|LkezPFEh\|ryP	NHzyTJo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
BHT-101	NFXJXINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NGrNcG9KSzVyPUGzMlg{PDVizszN	NImwdJM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
OCUB-M	NHTQXXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MWjJR\|UxRTF2LkG2NFIh\|ryP	NELSXmo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
MEG-01	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NWHnXXR4UUN3ME2xOE4{PzB6IN88US=>	MkjIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
RS4-11	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NE\hVmhKSzVyPUG0Mlc1OiEQvF2=	M{XKRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
MN-60	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M13rZ2lEPTB;MUSuO\|g6PCEQvF2=	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H1304	NUjzS2tjT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1j3bWlEPTB;MUWuNFQzPSEQvF2=	NHjkd4E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
Ramos-2G6-4C10	M4\wTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1S0bWlEPTB;MUWuNFU5OSEQvF2=	NYPLTnVsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
NCI-H2342	MmPRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MWnJR\|UxRTF3LkKwOFQh\|ryP	NH\0NYw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
LAN-6	MlLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHLsNGlKSzVyPUG1MlQ1OTRizszN	MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
JVM-2	M3XqUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVPJR\|UxRTF3LkW3OFgh\|ryP	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
P30-OHK	MlrFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NGrze5BKSzVyPUG2MlA3OTRizszN	MlvBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
C-33-A	MkjGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2LD[2lEPTB;MU[uOlIyPCEQvF2=	NWPlTmdHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
RPMI-8866	MkLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3z2WWlEPTB;MU[uPFQ6PiEQvF2=	MkDVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
NCI-H630	M1HCT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NWXnNYhNUUN3ME2xOk45PTN5IN88US=>	MluyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
KYSE-140	M2\TdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Mn3BTWM2OD1zNz6yNFI5KM7:TR?=	MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
T84	Ml[0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M37lRmlEPTB;MUiuPFY6PSEQvF2=	MmXLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
KU-19-19	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Mn;5TWM2OD1zOD65OlA5KM7:TR?=	MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
BALL-1	NHTJS4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NIj2c21KSzVyPUG5MlM{QTlizszN	NYLOTFR2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
Calu-6	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NI\NcIdKSzVyPUG5MlQ6OiEQvF2=	MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
EGI-1	NFiwc2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHvQTWZKSzVyPUG5MlU6QCEQvF2=	MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MFH-ino	M4\FOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NEXDbXFKSzVyPUG5Mlc1PTRizszN	NXjCO\|RHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
GB-1	M1S4fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFThNJRKSzVyPUKwMlM2OzVizszN	MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H1693	Mn3OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MUjJR\|UxRTJyLk[1NFUh\|ryP	M1\kTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
SW1116	NH7PWZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NH7RNYdKSzVyPUKwMlk{PjJizszN	Mom3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
H-EMC-SS	M3PUe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MWLJR\|UxRTJ{LkC0OUDPxE1?	NYqwd4c2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
D-502MG	M{LGSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXPJR\|UxRTJ{LkiyOlEh\|ryP	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
IA-LM	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NUTzWYw6UUN3ME2yN{4zPDl\|IN88US=>	NYi4WYRKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
SW1463	M3znWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MoL1TWM2OD1{Mz63PUDPxE1?	Mo\LQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
JAR	M1Pz[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NWC1Uow5UUN3ME2yOE4{Ojl\|IN88US=>	M1vFblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
HT	MkHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M33jemlEPTB;MkSuOFc2OyEQvF2=	NYrPT5lGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
LCLC-103H	M1vJUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M323[2lEPTB;MkSuPFQ1QSEQvF2=	MmLsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
SNU-449	M4j0UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHXse2lKSzVyPUK0Mlg4PDFizszN	NUj6OXNlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
KE-37	M1zBe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnfvTWM2OD1{NT6wPVI5KM7:TR?=	MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H1623	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MlOyTWM2OD1{Nz6xN\|A{KM7:TR?=	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
MOLT-13	NIn4XIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHfkTJRKSzVyPUK3MlM2OTZizszN	NUfpV\|MzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
COLO-741	NUXIXVN3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MknlTWM2OD1\|MT6zN\|M{KM7:TR?=	MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NB6	Mli3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NYH5S40{UUN3ME2zNk4zQDd4IN88US=>	MnTyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
MOLT-16	NUTtcG1yT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NYn4[m5MUUN3ME2zN{4xODV3IN88US=>	NWSwOW9bRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
IST-MES1	NYD0Zoh5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M{fUbmlEPTB;M{SuNFU1OSEQvF2=	MoDqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
A4-Fuk	M2nRUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NUnhUJZZUUN3ME2zOU4xPjZizszN	NIPvcHQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
CAL-85-1	NEjOXnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MX\JR\|UxRTN3LkK4NVch\|ryP	NHvkboQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
CCRF-CEM	NFHEU4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M3r2SWlEPTB;M{euNVU{PiEQvF2=	NWfyfYc1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HAL-01	MlrjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHvCRolKSzVyPUO4MlQ5QDlizszN	NXn5TYpyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
HEL	M2fiOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MX;JR\|UxRTR\|LkO0NFkh\|ryP	M4Xne\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFExQTR6MD:nQnNCVkeHUkyvZV4>
EW-1	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NGLVWoxKSzVyPUSzMlQ4PjhizszN	NIj6V4E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
MDA-MB-231	Ml3MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NYXKO5BvUUN3ME20OU4yOTl7IN88US=>	MkXSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>
ABC-1	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHrwXIVKSzVyPUS2Mlg2OzhizszN	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNFk1QDBxJ{7TRW5ITVJ:L3G+
NCI-H446	MmTqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MXHJR\|UxRTR6LkWwOVgh\|ryP	NVy3UmlSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
MHH-PREB-1	NWXjcWtbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MX7JR\|UxRTR7Lk[wNFch\|ryP	NEDXS409[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyODl2OECvK\|5USU6JRWK8M4E,
DOHH-2	NEPnPXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MmXwTWM2OD12OT62OlU3KM7:TR?=	NV7zb4NnRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTB7NEiwM{c,W0GQR1XSQE9iRg>?
GCT	M2DJTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1LjOGlEPTB;NEmuOlk4PiEQvF2=	MkT3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVA6PDhyLze+V2FPT0WUPD;hQi=>

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	LATS1 / p-LATS1 / YAP / CTGF; PubMed: 25712415 J Cell Mol Med Effects of 17-AAG on the expression of LATS1, p-LATS1, YAP and CTGF. The expression levels of YAP and CTGF proteins, indicated by Western blot assay, were down-regulated, while LATS1 was upregulated in a dose-dependent manner in 17-AAG treated groups compared to the untreated group. Cleaved PARP / Survivin; PubMed: 18827603 J Thorac Oncol Western analysis of expression levels of cleaved PARP and Survivin in MM cell lines. β-Actin served as loading control. pAKT / pMAPK / pRb; PubMed: 18682579 Neuro Oncol The phosphorylated states of signaling proteins involved in glioma growth are also affected by 17-AAG treatment. EGFR / PDGFR / AKT / MAPK / c-RAS; PubMed: 18682579 Neuro Oncol 17-AAG promotes the degradation of HSP90 client proteins that are involved in the pathology of glioblastoma multiforme (GBM). Glioma cell lines were treated with increasing concentrations of 17-AAG for 48 h, and protein lysates were run on Western blots. HSP90 client proteins known to be involved in gliomagenesis showed degradation while nonclient proteins remained unaffected by 17-AAG treatment. α-Synuclein / HSP90 / HSP70 / HSP32 / αB-Crystallin; PubMed: 20090920 PLoS One Immunoblot analysis of heat shock protein induction. Cells were treated with 17-AAG (1–200 nM, 24 h), or subjected to heat shock (HS: 44°C, 30 min, 24 h recovery) or to MG-132 (MG: 1 µM, 24 h). Cell lysates were prepared and immunoblot analysis was carried out with antibodies against the individual proteins as indicated on the right. Co, untreated control.	25712415 18827603 18682579 20090920
Immunofluorescence	β-catenin / E-cadherin; PubMed: 25290150 PLoS One Co-localization of β-catenin (Red) and E-cadherin (Green) was observed at the cell-cell junctions (white arrows) both in siCtrl and siCTGF cells after 17-AAG treatment. Scale bar is 20 µm. YAP / TAZ; PubMed: 25290150 PLoS One Reduction in cytoplasmic distribution accompanied by increased nuclear localization of YAP/TAZ was more apparent in cells treated with 45 nM 17-AAG (red channel for YAP/TAZ and blue channel for nucleus). Statistical comparisons were performed using one-way Kruskal-Wallis multiple comparison, ***p<0.001 compared with control (0 nM). STAT3; PubMed: 27279418 Mol Med Rep Effects of 17-AAG on STAT3 expression of H446 cells. (A) Control group; (B) 3.125 mg/l; (C) 6.25 mg/l. 17-AAG, 17-allylamino-17-demethoxygel-danamycin; STAT3, signal transducer and activator of transcription 3; DAPI, 4′,6-diamidino-2-phenylindole.	25290150 27279418
Growth inhibition assay	Cell viability; PubMed: 18682579 Neuro Oncol 17-AAG inhibits the growth of human glioma cell lines. Human glioma cell lines and a nontumorigenic fibroblast cell line were treated with increasing concentrations of 17-AAG for 4 days, and the effect on cell growth was assessed by a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay. The 50% inhibitory concentration (IC50) of all glioma cell lines ranged from 0.05 to 0.5 μM 17-AAG, as compared to 1.5 μM for the nontumorigenic cells.	18682579

In vivo

17-AAG displays significantly higher binding affinity for Hsp90 from 3T3-src, B16 or CT26 xenografts in nude mice with IC50 values of 8-35 nM as compared with that from the normal tissues with IC50 values of 200-600 nM. ^[1] Administration of 17-AAG (~50 mg/kg) causes significant decline in AR, HER2, HER3, and Akt expression in a dose-dependent manner with >50% decline at dose of 50 mg/kg, resulting in the dose-dependent inhibition of androgen-dependent (CWR22) and -independent (CWR22R and CWRSA6) prostate cancer xenografts growth by 67%, 80% and 68% at dose of 50 mg/kg, respectively. ^[2]

Protocol

Kinase Assay:^[1]	- Collapse Hsp90 binding assays: Purified native Hsp90 protein or cell lysates from HER-2-overexpressing cancer cells (BT474, N87, SKOV3 and SKBR3) or BT474 breast carcinoma cells in lysis buffer (20 mM HEPES, pH 7.3, 1 mM EDTA, 5 mM MgCl₂, 100 mM KCl) are incubated with various concentrations of 17-AAG for 30 minutes at 4 °C, and then incubated with biotin-GM linked to BioMag streptavidin magnetic beads for 1 hour at 4 °C. Tubes are placed on a magnetic rack, and the unbound supernatant removed. The magnetic beads are washed three times in lysis buffer and heated for 5 minutes at 95 °C in SDS–PAGE sample buffer. Samples are analysed on SDS protein gels, and western blots done using indicated antibodies. Bands in the western blots are quantified using the Bio-rad Fluor-S MultiImager, and the percentage inhibition of binding of Hsp90 to the biotin-GM is calculated. The IC50 reported is the concentration of 17-AAG needed to cause half-maximal inhibition of binding.
Cell Research:^[1]	- Collapse Cell lines: BT474, SKBR3, N87, SKOV3, MCF7, MDA468, Hs578T, Hs578Bst, A549, HT29, U87, SKMG3, HT1080, RPTEC, NDF, HMVEC, HMEC, HUVEC, and PBMC cells Concentrations: Dissolved in DMSO, final concentrations ~10 μM Incubation Time: 5 days Method: Cells are seeded in 96-well plates at 2,000 cells per well in a final culture volume of 100 μL for 24 hours before the addition of increasing concentrations of 17-AAG that is incubated for 5 days. Viable cell number is determined using the Celltiter 96 AQueous Nonradioactive Cell Proliferation Assay. The value of the background absorbance at 490 nm (A₄₉₀) of wells not containing cells is subtracted. Percentage of viable cells = (A₄₉₀ of 17-AAG treated sample/A₄₉₀ untreated cells) × 100. The IC50 is defined as the concentration that gave rise to 50% viable cell number. (Only for Reference)
Animal Research:^[2]	- Collapse Animal Models: Male nu/nu athymic mice inoculated s.c. with androgen-dependent CWR22 xenograft, and female nu/nu athymic mice inoculated s.c. with androgen-independent xenografts CWR22R and CWRSA6 Dosages: ~50 mg/kg Administration: Injection i.p. (Only for Reference)

References

Solubility (25°C)

In vitro	DMSO	100 mg/mL (170.73 mM)
	Water	Insoluble
	Ethanol	''5 mg/mL
In vivo	Add solvents to the product individually and in order(Data is from Selleck tests instead of citations): 5%DMSO+corn oil For best results, use promptly after mixing.	10mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information Download Tanespimycin (17-AAG) SDF

Molecular Weight	585.69
Formula	C₃₁H₄₃N₃O₈
CAS No.	75747-14-7
Storage	3 years-20°C powder 2 years-80°C in solvent
Synonyms	CP127374, NSC-330507, KOS 953
Smiles	CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage

mg/kg

Average weight of animals

Dosing volume per animal

Number of animals

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO+ % + % Tween 80+ % ddH₂O

Calculate Reset

Calculation results:

Working concentration： mg/ml；

Method for preparing DMSO master liquid: ： mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL， Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation：Take μL DMSO master liquid, next addμL PEG300， mix and clarify, next addμL Tween 80，mix and clarify, next add μL ddH₂O，mix and clarify.

Note：1.Please make sure the liquid is clear before adding the next solvent.
2.Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Bio Calculators

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

Serial Dilutions
Concertration (start):
Dilution-folds:

Computed Result

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2021-09-06)

NCT Number	Recruitment	interventions	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT00103272	Terminated	Drug: tanespimycin\|Drug: bortezomib	Adult Acute Basophilic Leukemia\|Adult Acute Eosinophilic Leukemia\|Adult Acute Megakaryoblastic Leukemia (M7)\|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)\|Adult Acute Monoblastic Leukemia (M5a)\|Adult Acute Monocytic Leukemia (M5b)\|Adult Acute Myeloblastic Leukemia With Maturation (M2)\|Adult Acute Myeloblastic Leukemia Without Maturation (M1)\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Acute Myelomonocytic Leukemia (M4)\|Adult Erythroleukemia (M6a)\|Adult Pure Erythroid Leukemia (M6b)\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Nodal Marginal Zone B-cell Lymphoma\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult T-cell Leukemia/Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides/Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|Waldenström Macroglobulinemia	National Cancer Institute (NCI)	April 2005	Phase 1
NCT00098488	Terminated	Drug: tanespimycin\|Biological: rituximab	B-cell Chronic Lymphocytic Leukemia\|Prolymphocytic Leukemia\|Refractory Chronic Lymphocytic Leukemia	National Cancer Institute (NCI)	April 2005	Phase 1
NCT00118248	Completed	Drug: tanespimycin	Recurrent Thyroid Cancer\|Stage IV Follicular Thyroid Cancer\|Stage IV Papillary Thyroid Cancer\|Thyroid Gland Medullary Carcinoma	National Cancer Institute (NCI)	December 2004	Phase 2
NCT00098423	Completed	Drug: tanespimycin\|Drug: cytarabine	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Basophilic Leukemia\|Adult Acute Eosinophilic Leukemia\|Adult Acute Megakaryoblastic Leukemia (M7)\|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)\|Adult Acute Monoblastic Leukemia (M5a)\|Adult Acute Monocytic Leukemia (M5b)\|Adult Acute Myeloblastic Leukemia With Maturation (M2)\|Adult Acute Myeloblastic Leukemia Without Maturation (M1)\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Acute Myelomonocytic Leukemia (M4)\|Adult Erythroleukemia (M6a)\|Adult Pure Erythroid Leukemia (M6b)\|Blastic Phase Chronic Myelogenous Leukemia\|Chronic Myelomonocytic Leukemia\|de Novo Myelodysplastic Syndromes\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Refractory Anemia With Excess Blasts in Transformation\|Relapsing Chronic Myelogenous Leukemia\|Secondary Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndromes	National Cancer Institute (NCI)	November 2004	Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
What kind of subtypes does this compound inhibit? HSP90α or HSP90β ?
Answer:
17-AAG can inhibit both HSP90α and HSP90β, but it is unclear how much are they affected respectively. You should note that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than that from normal cells according to this paper. http://www.nature.com.ezp-prod1.hul.harvard.edu/nature/journal/v425/n6956/full/nature01913.html

HSP (HSP90) Signaling Pathway Map

HSP (HSP90) Inhibitors with Unique Features

Selective HSP90 Inhibitor

NVP-BEP800 : HSP90β-selective, IC50=58 nM.
Most Potent HSP90 Inhibitor

KW-2478 : HSP90, IC50=3.8 nM.
HSP90 Inhibitor in Clinical Trial

17-DMAG (Alvespimycin) HCl : Phase II for Kidney Cancer.
Newest HSP90 Inhibitor

XL888 : ATP-competitive inhibitor of HSP90 with IC50 of 24 nM.

Related HSP (HSP90) Products

Zelavespib (PU-H71) ^New

Zelavespib (PU-H71, NSC 750424) is a potent and selective inhibitor of HSP90 with IC50 of 51 nM. Phase 1.
KNK437 ^New

KNK437 is a pan-HSP inhibitor, which inhibits the synthesis of inducible HSPs, including HSP105, HSP72, and HSP40.
VER155008 ^New

VER155008 (C07) is a potent Hsp70 family inhibitor with IC50 of 0.5 μM, 2.6 μM, and 2.6 μM in cell-free assays for HSP70, HSC70, and GRP78 (HSPA5, Bip), respectively, >100-fold selectivity over HSP90. VER155008 inhibits autophagy and causes reduced levels of HSP90 client proteins.
Luminespib (NVP-AUY922)

Luminespib (AUY-922, NVP-AUY922, VER-52296) is a highly potent HSP90 inhibitor for HSP90α/β with IC50 of 13 nM /21 nM in cell-free assays, weaker potency against the HSP90 family members GRP94 and TRAP-1, exhibits the tightest binding of any small-molecule HSP90 ligand. Luminespib (AUY-922, NVP-AUY922) effectively downregulates and destabilizes the IGF-1Rβ protein and results in growth inhibition, autophagy and apoptosis. Phase 2.
Ganetespib (STA-9090)

Ganetespib (STA-9090) is an HSP90 inhibitor with IC50 of 4 nM in OSA 8 cells, induces apoptosis of OSA cells while normal osteoblasts are not affected; active metabolite of STA-1474. Phase 3.
Alvespimycin (17-DMAG) HCl

Alvespimycin (17-DMAG, NSC 707545, BMS 826476, KOS 1022) HCl is a potent HSP90 inhibitor with IC50 of 62 nM in a cell-free assay. Phase 2.

Features:A synthetic derivative Geldanamycin, with lower hepatotoxicity than parent antibiotic & higher potency and bioavailability than the similar derivative 17-AAG.
Geldanamycin (NSC 122750)

Geldanamycin (NSC 122750) is a natural existing HSP90 inhibitor with K_d of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association. Geldanamycin attenuates virus infection-induced ALI (acute lung injury)/ARDS (acute respiratory distress syndrome) by reducing the host's inflammatory responses.
HSP990 (NVP-HSP990)

HSP990 (NVP-HSP990) is a novel, potent and selective HSP90 inhibitor for HSP90α/β with IC50 of 0.6 nM/0.8 nM. NVP-HSP990 induces cell cycle arrest and apoptosis.

Features:NVP-HSP990 is an orally available HSP90 inhibitor and is structurally distinct from other clinical HSP90 inhibitors.
Elesclomol (STA-4783)

Elesclomol (STA-4783) is a novel potent oxidative stress inducer that elicits pro-apoptosis events among tumor cells. Phase 3.
Onalespib (AT13387)

Onalespib (AT13387) is a selective potent Hsp90 inhibitor with IC50 of 18 nM in A375 cells, displays a long duration of anti-tumor activity. Phase 2.

Choose Your Country or Region

By Signaling Pathways

By product type

Tanespimycin (17-AAG)